Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
105,534,000,000 JPY
102,904,000,000 JPY
109,983,000,000 JPY
113,620,000,000 JPY
110,640,000,000 JPY
Operating revenue
6,575,000,000 JPY
7,189,000,000 JPY
7,244,000,000 JPY
8,043,000,000 JPY
7,715,000,000 JPY
Ordinary profit (loss)
3,960,000,000 JPY
5,569,000,000 JPY
4,585,000,000 JPY
6,447,000,000 JPY
4,482,000,000 JPY
8,175,000,000 JPY
5,115,000,000 JPY
9,438,000,000 JPY
4,734,000,000 JPY
9,345,000,000 JPY
Profit (loss)
3,919,000,000 JPY
4,516,000,000 JPY
4,476,000,000 JPY
5,076,000,000 JPY
4,663,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
Total number of issued shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
74,947,628 xbrli:shares
Net assets
124,507,000,000 JPY
64,952,000,000 JPY
124,661,000,000 JPY
64,812,000,000 JPY
122,710,000,000 JPY
64,642,000,000 JPY
123,395,000,000 JPY
64,525,000,000 JPY
105,062,000,000 JPY
163,297,000,000 JPY
Total assets
171,924,000,000 JPY
95,619,000,000 JPY
167,126,000,000 JPY
95,391,000,000 JPY
171,160,000,000 JPY
95,126,000,000 JPY
173,034,000,000 JPY
104,727,000,000 JPY
106,784,000,000 JPY
196,736,000,000 JPY
Net assets per share
2,172.83
1,118.83
2,175.52
1,116.42
2,142.07
1,113.61
2,154.05
1,111.61
1,409.97
2,214.13
Dividend paid per share
52
75
75
75
58
Interim dividend paid per share
20
30
30
30
20
Basic earnings (loss) per share
67.51
68.62
77.80
106.99
77.11
107.35
76.48
104.68
62.68
89.28
Diluted earnings per share
Equity-to-asset ratio
0.724 xbrli:pure
0.679 xbrli:pure
0.746 xbrli:pure
0.679 xbrli:pure
0.717 xbrli:pure
0.680 xbrli:pure
0.713 xbrli:pure
0.616 xbrli:pure
0.984 xbrli:pure
0.830 xbrli:pure
Rate of return on equity
0.060 xbrli:pure
0.032 xbrli:pure
0.070 xbrli:pure
0.050 xbrli:pure
0.069 xbrli:pure
0.050 xbrli:pure
0.060 xbrli:pure
0.048 xbrli:pure
0.045 xbrli:pure
0.041 xbrli:pure
Price-earnings ratio
26.32 xbrli:pure
25.90 xbrli:pure
24.78 xbrli:pure
18.02 xbrli:pure
28.50 xbrli:pure
20.48 xbrli:pure
28.25 xbrli:pure
20.64 xbrli:pure
31.89 xbrli:pure
22.39 xbrli:pure
Payout ratio
0.772 xbrli:pure
0.966 xbrli:pure
0.974 xbrli:pure
0.982 xbrli:pure
0.929 xbrli:pure
Net cash provided by (used in) operating activities
6,346,000,000 JPY
5,189,000,000 JPY
7,739,000,000 JPY
340,000,000 JPY
10,456,000,000 JPY
Net cash provided by (used in) investing activities
-2,560,000,000 JPY
-4,259,000,000 JPY
-2,943,000,000 JPY
14,939,000,000 JPY
-6,038,000,000 JPY
Net cash provided by (used in) financing activities
-4,112,000,000 JPY
-4,918,000,000 JPY
-5,117,000,000 JPY
-27,315,000,000 JPY
-3,735,000,000 JPY
Cash and cash equivalents
26,289,000,000 JPY
26,476,000,000 JPY
30,509,000,000 JPY
30,914,000,000 JPY
42,971,000,000 JPY
Number of employees
2,222 xbrli:pure
115 xbrli:pure
2,243 xbrli:pure
114 xbrli:pure
2,271 xbrli:pure
113 xbrli:pure
2,297 xbrli:pure
110 xbrli:pure
115 xbrli:pure
2,348 xbrli:pure
Total shareholder return
0.898 xbrli:pure
0.940 xbrli:pure
1.023 xbrli:pure
0.976 xbrli:pure
0.875 xbrli:pure
Total return on share price index
1.443 xbrli:pure
1.415 xbrli:pure
0.996 xbrli:pure
1.100 xbrli:pure
1.159 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.